EXECUTIVE ENGAGEMENTS
POOL
INTERACTIONS
PARTICIPANTS
VALIDATIONS
COMPANIES
* Login for a full stack data experience
DATE
JAN 2023
TABLES
122
PAGES
198
EDITION
19
PRICE
USD 5450
CODE
MCP-1241
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
What`s New for 2023?
»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
»Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
»Online interactive peer-to-peer collaborative bespoke updates
»Access to our digital archives and MarketGlass Research Platform
»Complimentary updates for one year
Looking Ahead to 2023
The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Global Regenerative Medicine Market to Reach $30.8 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Regenerative Medicine estimated at US$9.6 Billion in the year 2022, is projected to reach a revised size of US$30.8 Billion by 2030, growing at a CAGR of 15.8% over the analysis period 2022-2030. Cell Therapy, one of the segments analyzed in the report, is projected to record a 16.3% CAGR and reach US$15.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Gene Therapy segment is readjusted to a revised 15.7% CAGR for the next 8-year period.
The U.S. Market is Estimated at $2.8 Billion, While China is Forecast to Grow at 14.7% CAGR
The Regenerative Medicine market in the U.S. is estimated at US$2.8 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.2 Billion by the year 2030 trailing a CAGR of 14.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.4% and 13.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 11.2% CAGR.
SELECT PLAYERS
AlloSource; Anika Therapeutics, Inc.; Bioventus LLC; DePuy Synthes Spine, Inc.; Exactech, Inc.; Integra LifeSciences Holdings Corp.; LifeNet Health, Inc.; Medtronic, PLC; NovaBone Products LLC; NuVasive, Inc.; Orthofix International N.V.; Osiris Therapeutics, Inc.; Smith & Nephew plc; Stryker Corporation; Wright Medical Technology, Inc.; Zimmer Biomet Holdings, Inc.
SEGMENTS
» Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, Other Product Types) » Material Type (Biologically Derived, Synthetic, Genetically Engineered, Other Material Types) » Application (Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology, Other Applications)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
I. METHODOLOGY |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Influencer Market Insights |
World Market Trajectories |
Regenerative Medicine: A Preface |
Recent Market Activity |
An Overview of Regenerative Medicine in Bone and Joint Applications |
Current and Future Analysis |
Developed Markets Dominate, Developing to Drive Growth |
Regenerative Medicine - Past, Present & Future |
Another Revolution in the Making? |
Conventional Chemical Medicine Vs Regenerative Medicine |
Regenerative Medicine - Bypassing the Ethical Concerns |
Regenerative Medicine Throws Up Several New Therapies |
Current Global Market for Regenerative Medicine |
Market Potential |
Therapeutic Companies and Products in Regenerative Medicine - Current Status |
Regenerative Medicine – Global Key Competitors Percentage Market Share in 2022 (E) |
Competitive Market Presence - Strong/Active/Niche/Trivial for 52 Players Worldwide in 2022 (E) |
Impact of Covid-19 and a Looming Global Recession |
2. FOCUS ON SELECT PLAYERS |
AlloSource (US) |
Anika Therapeutics, Inc. (US) |
Bioventus LLC (US) |
DePuy Synthes Companies (US) |
DePuy Synthes Spine, Inc. (US) |
Exactech, Inc. (US) |
Integra LifeSciences Holdings Corp. (US) |
LifeNet Health, Inc. (US) |
Medtronic, plc (Ireland) |
NovaBone Products LLC (US) |
NuVasive, Inc. (US) |
Orthofix International N.V. (Netherlands) |
Osiris Therapeutics, Inc. (US) |
Smith & Nephew plc (UK) |
Stryker Corporation (US) |
Wright Medical Technology, Inc. (US) |
Zimmer Biomet Holdings, Inc. (US) |
3. MARKET TRENDS & DRIVERS |
A Combination of Factors to Drive Regenerative Medicine Market |
Burgeoning Global Population Offers Significant Growth Opportunities |
Aging Global Population: Need for New Effective Treatments |
Increasing Healthcare Spending in Emerging Markets: Opportunities in Store |
Government Support and Increased Private Sector Participation |
Investment and Funding Landscape |
Major M&A Activity and Strategic Alliances in Regenerative Medicine: 2011-2016 |
Recent Advancements in the Science of Regenerative Medicine |
Advanced Ceramics Gaining Preeminence in Regenerative Medicine Field |
3D Organ & Tissue Printing: Still in Early Stages |
Nanotechnology in Regenerative Medicine |
Issues to be Sorted Out |
Need for New Scientific and Technological Standards |
Standardized Guidelines |
Clinical Translation - Collaboration of Multidisciplinary Skills is Essential |
The Question of Apt Business Models - The Service and Product Approach |
Autologous or Service Approach Preferred by European Firms |
Allogenic or Product Approach - Slow to Develop |
Regenerative Medicine Requires Improved Biomaterials |
Investors Wary of Funding Regenerative Medicine |
Regenerative Medicine Field Lags Behind Due to Segregated Focus |
Challenges Encountered by Regenerative Medicine |
Scientific and Technological Challenges |
Barriers in Sharing Intellectual Property Rights |
Viable Manufacturing Technologies and Skilled Personnel Crucial |
Strict Regulations Push up Operational Costs |
Challenges Facing Autologous Cell Therapies |
4. GLOBAL MARKET PERSPECTIVE |
World Recent Past, Current & Future Analysis for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Gene Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Tissue Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Tissue Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Tissue Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Biologically Derived by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Biologically Derived by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Biologically Derived by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Synthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Synthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Synthetic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Genetically Engineered by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Genetically Engineered by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Genetically Engineered by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Other Material Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Other Material Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Other Material Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Musculoskeletal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Musculoskeletal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Musculoskeletal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Dermatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Dermatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Dermatology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Ophthalmology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030 |
World Regenerative Medicine Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030 |
III. MARKET ANALYSIS |
UNITED STATES |
Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E) |
USA Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
USA Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
USA 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030 |
USA Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
USA Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
USA 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030 |
USA Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
USA Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
USA 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030 |
CANADA |
Canada Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Canada Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Canada 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030 |
Canada Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Canada Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Canada 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030 |
Canada Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Canada Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Canada 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030 |
JAPAN |
Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E) |
Japan Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Japan Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Japan 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030 |
Japan Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Japan Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Japan 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030 |
Japan Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Japan Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Japan 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030 |
CHINA |
Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E) |
China Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
China Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
China 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030 |
China Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
China Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
China 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030 |
China Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
China Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
China 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030 |
EUROPE |
Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E) |
Europe Recent Past, Current & Future Analysis for Regenerative Medicine by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
Europe Historic Review for Regenerative Medicine by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Europe 16-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030 |
Europe Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Europe Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Europe 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030 |
Europe Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Europe Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Europe 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030 |
Europe Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Europe Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Europe 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030 |
FRANCE |
Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E) |
France Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
France Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
France 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030 |
France Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
France Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
France 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030 |
France Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
France Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
France 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030 |
GERMANY |
Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E) |
Germany Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Germany Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Germany 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030 |
Germany Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Germany Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Germany 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030 |
Germany Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Germany Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Germany 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030 |
ITALY |
Italy Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Italy Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Italy 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030 |
Italy Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Italy Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Italy 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030 |
Italy Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Italy Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Italy 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030 |
UNITED KINGDOM |
Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E) |
UK Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
UK Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
UK 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030 |
UK Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
UK Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
UK 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030 |
UK Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
UK Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
UK 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030 |
REST OF EUROPE |
Rest of Europe Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Rest of Europe Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Rest of Europe 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030 |
Rest of Europe Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Rest of Europe Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Rest of Europe 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030 |
Rest of Europe Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Rest of Europe Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Rest of Europe 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030 |
ASIA-PACIFIC |
Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E) |
Asia-Pacific Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Asia-Pacific Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Asia-Pacific 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030 |
Asia-Pacific Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Asia-Pacific Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Asia-Pacific 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030 |
Asia-Pacific Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Asia-Pacific Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Asia-Pacific 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030 |
REST OF WORLD |
Rest of World Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Rest of World Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Rest of World 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030 |
Rest of World Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Rest of World Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Rest of World 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030 |
Rest of World Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Rest of World Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR |
Rest of World 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030 |
IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com